Brazil vs Portugal: The number of people with susceptibility test result for rifampicin
Brazil
50.47
in 2021
Portugal
54.52
in 2021
Brazil rank
114th
Portugal rank
112th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Portugal
How they compare
Portugal currently reports 54.52 against 50.47 in Brazil, a difference of 4.05.
That makes Portugal's figure about 1.1 times Brazil's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Portugal ahead.
Brazil ranks 114th and Portugal ranks 112th of 146 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.74 | 58.49 | 16.75 | Portugal |
| 2020s | 51.96 | 53.61 | 1.66 | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Portugal?
- Portugal, at 54.52 against 50.47 in Brazil as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Portugal?
- 4.05, with Portugal ahead.
- How many years of comparable data are there for Brazil and Portugal?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Portugal rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 114th and Portugal ranks 112th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.